P B Andersson|D E Goodkin - JoVE Visualize

Showing results (61-70 of 89) with videos related to

Pageof 9

Sort By:

Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 1999

Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1aD C Mohr, W Likosky, A C Boudewyn, et al.

Neuroscience|October 1, 1993

Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrierD M Reid, V H Perry, P B Andersson, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|July 17, 1999

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosisD C Mohr, D E Goodkin, L Masuoka, et al.

Annals of Neurology|January 1, 1995

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.

Lancet (London, England)|October 26, 1991

Overview of azathioprine treatment in multiple sclerosisP L Yudkin, G W Ellison, A Ghezzi, et al.

Neurology|September 26, 2002

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MSR G Ghalie, G Edan, M Laurent, et al.

The Online Journal of Current Clinical Trials|September 25, 1992

Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicityD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.

Neurology|July 23, 1998

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosisD E Goodkin, R P Kinkel, B Weinstock-Guttman, et al.

Neurology|December 17, 1998

A serial study of new MS lesions and the white matter from which they ariseD E Goodkin, W D Rooney, R Sloan, et al.

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 14, 2000

Antibodies to Chlamydia trachomatis in patients presenting with ectopic pregnancy at Groote Schuur HospitalS K Tregoning, R C Ballard, P B Andersson, et al.

Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:

Pageof 9

Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 1999

Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1aD C Mohr, W Likosky, A C Boudewyn, et al.

Neuroscience|October 1, 1993

Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrierD M Reid, V H Perry, P B Andersson, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|July 17, 1999

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosisD C Mohr, D E Goodkin, L Masuoka, et al.

Annals of Neurology|January 1, 1995

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.

Lancet (London, England)|October 26, 1991

Overview of azathioprine treatment in multiple sclerosisP L Yudkin, G W Ellison, A Ghezzi, et al.

Neurology|September 26, 2002

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MSR G Ghalie, G Edan, M Laurent, et al.

The Online Journal of Current Clinical Trials|September 25, 1992

Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicityD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.

Neurology|July 23, 1998

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosisD E Goodkin, R P Kinkel, B Weinstock-Guttman, et al.

Neurology|December 17, 1998

A serial study of new MS lesions and the white matter from which they ariseD E Goodkin, W D Rooney, R Sloan, et al.

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 14, 2000

Antibodies to Chlamydia trachomatis in patients presenting with ectopic pregnancy at Groote Schuur HospitalS K Tregoning, R C Ballard, P B Andersson, et al.

Pageof 9